TRUP vs. OSCR, ALHC, CLOV, NEUE, BHG, MOH, UNH, ELV, CI, and HUM
Should you be buying Trupanion stock or one of its competitors? The main competitors of Trupanion include Oscar Health (OSCR), Alignment Healthcare (ALHC), Clover Health Investments (CLOV), NeueHealth (NEUE), Bright Health Group (BHG), Molina Healthcare (MOH), UnitedHealth Group (UNH), Elevance Health (ELV), The Cigna Group (CI), and Humana (HUM). These companies are all part of the "hospital & medical service plans" industry.
Oscar Health (NYSE:OSCR) and Trupanion (NASDAQ:TRUP) are both finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, community ranking, media sentiment, risk, earnings, dividends, valuation, profitability and analyst recommendations.
75.7% of Oscar Health shares are owned by institutional investors. 25.1% of Oscar Health shares are owned by insiders. Comparatively, 5.5% of Trupanion shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Trupanion has lower revenue, but higher earnings than Oscar Health. Oscar Health is trading at a lower price-to-earnings ratio than Trupanion, indicating that it is currently the more affordable of the two stocks.
Trupanion received 492 more outperform votes than Oscar Health when rated by MarketBeat users. Likewise, 66.41% of users gave Trupanion an outperform vote while only 55.17% of users gave Oscar Health an outperform vote.
In the previous week, Oscar Health had 11 more articles in the media than Trupanion. MarketBeat recorded 22 mentions for Oscar Health and 11 mentions for Trupanion. Oscar Health's average media sentiment score of 0.68 beat Trupanion's score of 0.37 indicating that Trupanion is being referred to more favorably in the news media.
Oscar Health has a net margin of -0.82% compared to Oscar Health's net margin of -2.31%. Trupanion's return on equity of -5.77% beat Oscar Health's return on equity.
Oscar Health presently has a consensus price target of $18.57, indicating a potential downside of 7.19%. Trupanion has a consensus price target of $32.80, indicating a potential upside of 16.89%. Given Oscar Health's higher possible upside, analysts clearly believe Trupanion is more favorable than Oscar Health.
Oscar Health has a beta of 1.68, suggesting that its stock price is 68% more volatile than the S&P 500. Comparatively, Trupanion has a beta of 1.82, suggesting that its stock price is 82% more volatile than the S&P 500.
Summary
Oscar Health beats Trupanion on 11 of the 19 factors compared between the two stocks.
Get Trupanion News Delivered to You Automatically
Sign up to receive the latest news and ratings for TRUP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TRUP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Trupanion Competitors List
Related Companies and Tools
